Long COVID and cell energy study
Part of Hormones & metabolism, Infections, Lungs & breathing clinical trials.
This study looks at how cells make energy in people with Long COVID compared to people who fully recovered. It involves a blood draw, a small muscle sample, and a skin biopsy to understand why symptoms last.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have been diagnosed with Long COVID by a doctor based on the WHO definition.
- Your Long COVID symptoms have lasted at least 6 months.
- You had a confirmed COVID-19 infection in the past.
- You are 18 years or older.
- Your ability to do daily activities dropped from normal to limited since COVID (grade 2–4 on a scale).
- You do not have other chronic diseases or take medicines that change how your body uses energy.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks at how COVID-19 affects people in the long term. It aims to understand the lasting symptoms (often called long COVID) and how they impact your daily life. You may join if you have ongoing symptoms after COVID-19 that bother you or reduce your quality of life.
This study is testing a new, non-invasive way to diagnose Long COVID using a simple bioelectrical assessment. It might help if you've had COVID-19 and have been dealing with ongoing symptoms for 12 weeks or longer.
This study looks at how long-term COVID affects your body and tests an exercise program to help with recovery. It compares people with long COVID to those who recovered fully.
This study uses special imaging (PET/CT) to understand ongoing breathing problems or tiredness after COVID-19. It aims to learn how inflammation and changes in the body connect to symptoms that last more than 3 months.
This study tests a program to help reduce fatigue and other symptoms in people with Long COVID. It involves using an internet-connected device to access the program remotely.
This trial tests a natural compound to see if it can reduce ongoing inflammation and symptoms like fatigue, brain fog, or shortness of breath that linger after a COVID-19 infection. It's for people who still have symptoms at least 2 months after getting sick.
Hear when a new Long COVID trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.